Discover how EP&T Global's collaboration with Westfield enhanced energy efficiency, cutting costs and emissions by 20% at ...

Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the first patient treated under an ...

Lisa Ricciardi, Cognition’s president and CEO, added, “Zervimesine delivered positive clinical data during 2024 from two key Phase 2 studies: ...

The View Hospital, in affiliation with Cedars Sinai, is proud to announce a groundbreaking achievement, having successfully ...

Skye‘s prime accomplishment in 2024 was the initiation and rapid advancement of its comprehensive Phase 2a clinical study of nimacimab, a ...

Another bill, which would have mandated prayer and Bible study time in Texas classrooms, has not yet cleared the Texas Senate ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...

Discover key insights on U.S. stock performance, Fed policy updates, earnings trends, and sector highlights from tech to ...

ELEV decides to stop developing its lead drug after disappointing data from an early-stage study evaluating its sole clinical-stage drug in gastric cancers.

Analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Sutro Biopharma in a research note issued ...

We recently published a list of 12 Best Battery Stocks to Buy According to Billionaires. In this article, we are going to ...